171 related articles for article (PubMed ID: 21605084)
1. Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics.
Marechal X; Montaigne D; Marciniak C; Marchetti P; Hassoun SM; Beauvillain JC; Lancel S; Neviere R
Clin Sci (Lond); 2011 Nov; 121(9):405-13. PubMed ID: 21605084
[TBL] [Abstract][Full Text] [Related]
2. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats.
Ascensão A; Lumini-Oliveira J; Machado NG; Ferreira RM; Gonçalves IO; Moreira AC; Marques F; Sardão VA; Oliveira PJ; Magalhães J
Clin Sci (Lond); 2011 Jan; 120(1):37-49. PubMed ID: 20666733
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart.
Montaigne D; Marechal X; Baccouch R; Modine T; Preau S; Zannis K; Marchetti P; Lancel S; Neviere R
Toxicol Appl Pharmacol; 2010 May; 244(3):300-7. PubMed ID: 20096298
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin induces mitochondrial permeability transition and contractile dysfunction in the human myocardium.
Montaigne D; Marechal X; Preau S; Baccouch R; Modine T; Fayad G; Lancel S; Neviere R
Mitochondrion; 2011 Jan; 11(1):22-6. PubMed ID: 20599629
[TBL] [Abstract][Full Text] [Related]
5. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
Zhou S; Starkov A; Froberg MK; Leino RL; Wallace KB
Cancer Res; 2001 Jan; 61(2):771-7. PubMed ID: 11212281
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine A normalizes mitochondrial coupling, reactive oxygen species production, and inflammation and partially restores skeletal muscle maximal oxidative capacity in experimental aortic cross-clamping.
Pottecher J; Guillot M; Belaidi E; Charles AL; Lejay A; Gharib A; Diemunsch P; Geny B
J Vasc Surg; 2013 Apr; 57(4):1100-1108.e2. PubMed ID: 23332985
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest.
Oka N; Wang L; Mi W; Zhu W; Honjo O; Caldarone CA
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):123-30, 130.e1-2. PubMed ID: 18179928
[TBL] [Abstract][Full Text] [Related]
8. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin.
Solem LE; Heller LJ; Wallace KB
J Mol Cell Cardiol; 1996 May; 28(5):1023-32. PubMed ID: 8762040
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality.
Larche J; Lancel S; Hassoun SM; Favory R; Decoster B; Marchetti P; Chopin C; Neviere R
J Am Coll Cardiol; 2006 Jul; 48(2):377-85. PubMed ID: 16843190
[TBL] [Abstract][Full Text] [Related]
11. Calcium-induced cardiac mitochondrial dysfunction is predominantly mediated by cyclosporine A-dependent mitochondrial permeability transition pore.
Yarana C; Sripetchwandee J; Sanit J; Chattipakorn S; Chattipakorn N
Arch Med Res; 2012 Jul; 43(5):333-8. PubMed ID: 22824212
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine A-induced apoptosis in renal tubular cells is related to oxidative damage and mitochondrial fission.
de Arriba G; Calvino M; Benito S; Parra T
Toxicol Lett; 2013 Mar; 218(1):30-8. PubMed ID: 23347876
[TBL] [Abstract][Full Text] [Related]
13. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
14. Postconditioning inhibits mPTP opening independent of oxidative phosphorylation and membrane potential.
Paillard M; Gomez L; Augeul L; Loufouat J; Lesnefsky EJ; Ovize M
J Mol Cell Cardiol; 2009 Jun; 46(6):902-9. PubMed ID: 19254723
[TBL] [Abstract][Full Text] [Related]
15. Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A.
Mott JL; Zhang D; Freeman JC; Mikolajczak P; Chang SW; Zassenhaus HP
Biochem Biophys Res Commun; 2004 Jul; 319(4):1210-5. PubMed ID: 15194495
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial permeability transition pore opening induces the initial process of renal calcium crystallization.
Niimi K; Yasui T; Hirose M; Hamamoto S; Itoh Y; Okada A; Kubota Y; Kojima Y; Tozawa K; Sasaki S; Hayashi Y; Kohri K
Free Radic Biol Med; 2012 Apr; 52(7):1207-17. PubMed ID: 22285391
[TBL] [Abstract][Full Text] [Related]
17. Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling.
Marques-Aleixo I; Santos-Alves E; Torrella JR; Oliveira PJ; Magalhães J; Ascensão A
Cardiovasc Toxicol; 2018 Feb; 18(1):43-55. PubMed ID: 28536949
[TBL] [Abstract][Full Text] [Related]
18. [Melatonin recovers ischemic tolerance and decreases the sensitivity of mitochondrial permeability transition pore opening in the heart of aging rats].
Sahach VF; Rudyk OV; Vavilova HL; Kotsiuruba AV; Tkachenko IuP
Fiziol Zh (1994); 2006; 52(3):3-14. PubMed ID: 16909751
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mitochondrial remodeling by cyclosporine A preserves myocardial performance in a neonatal rabbit model of cardioplegic arrest.
Oka N; Wang L; Mi W; Caldarone CA
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):585-93. PubMed ID: 18329475
[TBL] [Abstract][Full Text] [Related]
20. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.
Solem LE; Henry TR; Wallace KB
Toxicol Appl Pharmacol; 1994 Dec; 129(2):214-22. PubMed ID: 7527602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
